<i>Sideritis scardica</i> Extracts Demonstrate Neuroprotective Activity against Aβ<sub>25–35</sub> Toxicity

Alzheimer’s disease (AD) is the most prevalent neurodegenerative condition, primarily affecting seniors. Despite the significant time and money spent over the past few decades, no therapy has been developed yet. In recent years, the research has focused on ameliorating the cytotoxic amyloid beta (Aβ...

Full description

Bibliographic Details
Main Authors: Antonis Ververis, Kristia Ioannou, Sotiris Kyriakou, Niki Violaki, Mihalis I. Panayiotidis, Michael Plioukas, Kyproula Christodoulou
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Plants
Subjects:
Online Access:https://www.mdpi.com/2223-7747/12/8/1716
_version_ 1797603772814327808
author Antonis Ververis
Kristia Ioannou
Sotiris Kyriakou
Niki Violaki
Mihalis I. Panayiotidis
Michael Plioukas
Kyproula Christodoulou
author_facet Antonis Ververis
Kristia Ioannou
Sotiris Kyriakou
Niki Violaki
Mihalis I. Panayiotidis
Michael Plioukas
Kyproula Christodoulou
author_sort Antonis Ververis
collection DOAJ
description Alzheimer’s disease (AD) is the most prevalent neurodegenerative condition, primarily affecting seniors. Despite the significant time and money spent over the past few decades, no therapy has been developed yet. In recent years, the research has focused on ameliorating the cytotoxic amyloid beta (Aβ) peptide aggregates and the increased elevated oxidative stress, two interconnected main AD hallmarks. Medicinal plants constitute a large pool for identifying bioactive compounds or mixtures with a therapeutic effect. <i>Sideritis scardica</i> (SS) has been previously characterized as neuroprotective toward AD. We investigated this ability of SS by generating eight distinct solvent fractions, which were chemically characterized and assessed for their antioxidant and neuroprotective potential. The majority of the fractions were rich in phenolics and flavonoids, and all except one showed significant antioxidant activity. Additionally, four SS extracts partly rescued the viability in Aβ<sub>25–35</sub>-treated SH-SY5Y human neuroblastoma cells, with the initial aqueous extract being the most potent and demonstrating similar activity in retinoic-acid-differentiated cells as well. These extracts were rich in neuroprotective substances, such as apigenin, myricetin-3-galactoside, and ellagic acid. Our findings indicate that specific SS mixtures can benefit the pharmaceutical industry to develop herbal drugs and functional food products that may alleviate AD.
first_indexed 2024-03-11T04:36:50Z
format Article
id doaj.art-eb4be2cec4f646f48ff58d135e30940b
institution Directory Open Access Journal
issn 2223-7747
language English
last_indexed 2024-03-11T04:36:50Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Plants
spelling doaj.art-eb4be2cec4f646f48ff58d135e30940b2023-11-17T21:00:37ZengMDPI AGPlants2223-77472023-04-01128171610.3390/plants12081716<i>Sideritis scardica</i> Extracts Demonstrate Neuroprotective Activity against Aβ<sub>25–35</sub> ToxicityAntonis Ververis0Kristia Ioannou1Sotiris Kyriakou2Niki Violaki3Mihalis I. Panayiotidis4Michael Plioukas5Kyproula Christodoulou6Neurogenetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, CyprusNeurogenetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, CyprusDepartment of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, CyprusDepartment of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, Nicosia 2417, CyprusDepartment of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, CyprusDepartment of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, Nicosia 2417, CyprusNeurogenetics Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, CyprusAlzheimer’s disease (AD) is the most prevalent neurodegenerative condition, primarily affecting seniors. Despite the significant time and money spent over the past few decades, no therapy has been developed yet. In recent years, the research has focused on ameliorating the cytotoxic amyloid beta (Aβ) peptide aggregates and the increased elevated oxidative stress, two interconnected main AD hallmarks. Medicinal plants constitute a large pool for identifying bioactive compounds or mixtures with a therapeutic effect. <i>Sideritis scardica</i> (SS) has been previously characterized as neuroprotective toward AD. We investigated this ability of SS by generating eight distinct solvent fractions, which were chemically characterized and assessed for their antioxidant and neuroprotective potential. The majority of the fractions were rich in phenolics and flavonoids, and all except one showed significant antioxidant activity. Additionally, four SS extracts partly rescued the viability in Aβ<sub>25–35</sub>-treated SH-SY5Y human neuroblastoma cells, with the initial aqueous extract being the most potent and demonstrating similar activity in retinoic-acid-differentiated cells as well. These extracts were rich in neuroprotective substances, such as apigenin, myricetin-3-galactoside, and ellagic acid. Our findings indicate that specific SS mixtures can benefit the pharmaceutical industry to develop herbal drugs and functional food products that may alleviate AD.https://www.mdpi.com/2223-7747/12/8/1716<i>Sideritis scardica</i>Alzheimer’s diseaseplant extractsneuroprotectionantioxidantamyloid beta
spellingShingle Antonis Ververis
Kristia Ioannou
Sotiris Kyriakou
Niki Violaki
Mihalis I. Panayiotidis
Michael Plioukas
Kyproula Christodoulou
<i>Sideritis scardica</i> Extracts Demonstrate Neuroprotective Activity against Aβ<sub>25–35</sub> Toxicity
Plants
<i>Sideritis scardica</i>
Alzheimer’s disease
plant extracts
neuroprotection
antioxidant
amyloid beta
title <i>Sideritis scardica</i> Extracts Demonstrate Neuroprotective Activity against Aβ<sub>25–35</sub> Toxicity
title_full <i>Sideritis scardica</i> Extracts Demonstrate Neuroprotective Activity against Aβ<sub>25–35</sub> Toxicity
title_fullStr <i>Sideritis scardica</i> Extracts Demonstrate Neuroprotective Activity against Aβ<sub>25–35</sub> Toxicity
title_full_unstemmed <i>Sideritis scardica</i> Extracts Demonstrate Neuroprotective Activity against Aβ<sub>25–35</sub> Toxicity
title_short <i>Sideritis scardica</i> Extracts Demonstrate Neuroprotective Activity against Aβ<sub>25–35</sub> Toxicity
title_sort i sideritis scardica i extracts demonstrate neuroprotective activity against aβ sub 25 35 sub toxicity
topic <i>Sideritis scardica</i>
Alzheimer’s disease
plant extracts
neuroprotection
antioxidant
amyloid beta
url https://www.mdpi.com/2223-7747/12/8/1716
work_keys_str_mv AT antonisververis isideritisscardicaiextractsdemonstrateneuroprotectiveactivityagainstabsub2535subtoxicity
AT kristiaioannou isideritisscardicaiextractsdemonstrateneuroprotectiveactivityagainstabsub2535subtoxicity
AT sotiriskyriakou isideritisscardicaiextractsdemonstrateneuroprotectiveactivityagainstabsub2535subtoxicity
AT nikiviolaki isideritisscardicaiextractsdemonstrateneuroprotectiveactivityagainstabsub2535subtoxicity
AT mihalisipanayiotidis isideritisscardicaiextractsdemonstrateneuroprotectiveactivityagainstabsub2535subtoxicity
AT michaelplioukas isideritisscardicaiextractsdemonstrateneuroprotectiveactivityagainstabsub2535subtoxicity
AT kyproulachristodoulou isideritisscardicaiextractsdemonstrateneuroprotectiveactivityagainstabsub2535subtoxicity